
Join to view full profile
1365 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-1900
Fax+1 404-778-3002
Dr. Carlisle is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jennifer Carlisle is an oncologist in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital and Emory University Hospital Midtown. She received her medical degree from University of Florida College of Medicine and has been in practice 6 years. She specializes in thoracic cancer and is experienced in carcinoid tumors of the lung, thymoma, small cell lung cancer, non-small cell lung cancer, and malignant pleural mesothelioma.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2011 - 2014
University of Florida College of MedicineClass of 2011
Certifications & Licensure
GA State Medical License 2015 - 2028
MO State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha omega alpha medical honor society, junior year University of Florida College of Medicine, 2010
- University Scholar Four Year Scholar, Valedectorian University of Florida, 2007
Clinical Trials
- Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer Start of enrollment: 2021 Jan 22
Publications & Presentations
PubMed
- Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.Jennifer W Carlisle, Katherine O'Reilly, Xiyuan Angel Ji, Jeffrey M Switchenko, Conor E Steuer
JCO Oncology Practice. 2026-07-08 - Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.Mattie Kilpatrick, Parker Gundersen, Katherine O'Reilly, Subir Goyal, Laura Sun
Clinical Lung Cancer. 2026-07-01 - 1 citationsExposed phosphatidylserine is an inhibitory molecule in T cell exhaustion.Christopher B Medina, Ewelina Sobierajska, Minghao Gong, Daniel T McManus, Maheshwor Thapa
Nature. 2026-05-01
Press Mentions
Outpatient Tarlatamab Administration Feasible in Relapsed SCLC with Close MonitoringMay 28th, 2025
R. Donald Harvey III, PharmD, on Vanguard Oncopharmacology in Lung CancerOctober 8th, 2021
Advaxis Announces Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at the IASLC 2020 Targeted Therapies of Lung Cancer MeetingFebruary 20th, 2020
Professional Memberships
- Member
- SITCMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









